The GT1708F project has been approved for clinical trials in China

(Summary description)

The GT1708F project has been approved for clinical trials in China

(Summary description)

Information
Officially listed on the Hong Kong Stock Exchange (Stock Code:9939.HK)
Kintor pharmaceutical and Sinopharm signed a strategic cooperation agreement
The GT1708F project has been approved for clinical trials in China

Scan the QR code to read on your phone